Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

Oxford University

Tag: oxford university

Read all Latest Updates on and about Oxford University - Page 6

Oxford University is a collegiate research university in Oxford, England. It is the oldest university in the English-speaking world and the world's second-oldest university in continuous operation.

AstraZeneca restarts COVID-19 vaccine trials in UK

Ruchika Sharma14 Sept 2020 1:00 PM IST

It added that safety reviewers had recommended to Britain's Medicines Health Regulatory Authority(MHRA) that it was safe to resume the British trials.

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

AstraZeneca still aiming for Oxford COVID vaccine by 2020 end, says CEO

Ruchika Sharma11 Sept 2020 1:04 PM IST

The trial was halted after a person in the UK who was participating in it got sick, triggering a review of safety data.

Serum Institute halts COVID vaccine trials in India

MD Bureau11 Sept 2020 10:00 AM IST

In a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...

Urgently reviewing AstraZeneca COVID-19 vaccine trial data, says Britain medical regulator

Ruchika Sharma11 Sept 2020 8:45 AM IST

UK: Britain's medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca AZN.L can restart...

Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India

Ruchika Sharma10 Sept 2020 1:58 PM IST

New Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...

AstraZeneca halts COVID19 vaccine trial after recipient unexplained illness

Ruchika Sharma9 Sept 2020 1:05 PM IST

New York: Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's...

Oxford COVID vaccine phase 2 trial to begin in PGI Chandigarh

MD Bureau29 Aug 2020 9:30 AM IST

PGI Chandigarh has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between the Indian...

Oxford COVID vaccine Phase 2 trial begins at Pune hospital

MD Bureau27 Aug 2020 10:00 AM IST

New Delhi : The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two...

Serum Institute shuns reports of commercializing Covishield, says will sell only after successful trial

MD Bureau24 Aug 2020 1:30 PM IST

"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.

India will get COVID-19 vaccine by 2020 end: Union Health Minister

MD Bureau24 Aug 2020 12:45 PM IST

The Ministry of Health and Family Welfare said that one of the three Covid-19 vaccine candidates has entered the third phase of the pre- clinical...

COVID-19 vaccine candidate to enter phase 3 of pre-clinical human trial: Health Ministry

MD Bureau19 Aug 2020 12:00 PM IST

While the officials did not reveal the names of the vaccine candidates while speaking about their testing phase, it could be gathered that the vaccine...

Govt to discuss procurement, logistics, priority groups for Covid-19 vaccine

Ruchika Sharma13 Aug 2020 9:00 AM IST

The committee on vaccine administration will engage with all stakeholders including state governments and vaccine manufacturers and its terms of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok